ST
ARCT icon

Spot Trading’s Arcturus Therapeutics ARCT Stock Holding History

Spot Trading’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-286
Closed -$8K – 3287
2016
Q1 		$8K Hold
286
– – ﹤0.01% 3168
2015
Q4 		$13K Buy
+286
New +$12.9K ﹤0.01% 3292
2014
Q4 		– Sell
-6,057
Closed -$655K – 3991
2014
Q3 		$655K Buy
+6,057
New +$789K ﹤0.01% 2376

Other funds holding ARCT

Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $214M AUM 62.74% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
KCM
Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return
VMI
VHCP Management II New York $379M AUM 421.62% 1-Year Est. Return

Spot Trading's ARCT Position: Q4 2014 in Review

Spot Trading sold out of Arcturus Therapeutics (ARCT) in Q4 2014, closing a stake of 2,355 shares — an estimated $254K sold.

Spot Trading first reported a position in ARCT in Q2 2014 and held it in 2 quarters. The position peaked at $318K in Q2 2014. 28 funds tracked by Wall St. Rank hold ARCT as of Q4 2014.

  • Spot Trading reported no remaining Arcturus Therapeutics position as of Q4 2014 after selling out during the quarter.
  • Spot Trading sold 2,355 Arcturus Therapeutics shares in Q4 2014, an estimated $254K.
  • Spot Trading first reported a position in Arcturus Therapeutics in Q2 2014 and held it in 2 quarters.
  • Spot Trading's Arcturus Therapeutics position peaked at $318K in Q2 2014.
  • 28 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q4 2014.

Based on Spot Trading's 13F filing for Q4 2014, filed 13 Feb 2015.